Sedentary Behavior Interrupted Randomized Controlled Trial (P2)

Sponsor
University of California, San Diego (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03473145
Collaborator
(none)
405
1
3
60
6.7

Study Details

Study Description

Brief Summary

Epidemiological findings indicate that older adults do not meet physical activity (PA) guidelines & spend up to 11 hrs/day sitting. Given the high prevalence of sedentary behavior (SB), the higher chronic disease risk in this population, & the age-associated challenges of meeting traditional PA guidelines, involving longer bouts of moderate PA, the investigators hypothesize that older adult health will benefit from new strategies to interrupt sitting. This protocol "Sedentary Behavior Interrupted: A randomized trial of 3-month effects on biomarkers of healthy aging and physical functioning in the real world (Project 2)" is part of a National Institutes of Aging Program Grant called "Sedentary Time & Aging Mortality and Physical Function (STAR). The overall purpose of the STAR program to is to better understand how to interrupt sitting time and the consequences for healthy aging in postmenopausal women. This protocol (also referred to Project 2 of the STAR program) is a 3-arm randomized control trial designed to assess ways of interrupting sitting in 405 overweight, postmenopausal women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health Coaching
  • Device: activPAL inclinometer
  • Other: Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
N/A

Detailed Description

Primary Aims:

In our primary biomarker outcomes of glucose regulation (fasting insulin & glucose, HbA1c,

HOMA-IR) & blood pressure (BP):
  1. Investigate the 12 week effects of increased standing and additional brief sit-to-stand compared to attention controls.

  2. Investigate the dose-response effects of behavioral change on the biomarkers & BP.

Secondary aims

  1. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on physical, emotional & cognitive functioning.

  2. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on in vivo skeletal muscle mitochondrial function.

Exploratory aims

  1. Explore the possible modifying effect of age on the relationship between intervention conditions & primary & secondary outcomes.

  2. Explore the psychosocial & environmental mediators & moderators of changes in sitting time, standing time, and transitions.

  3. Explore differences in outcomes between the 2 sitting interruption conditions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
405 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Sedentary Behavior Interrupted: A Randomized Trial of 3-month Effects on Biomarkers of Healthy Aging and Physical Functioning in the Real World (Project 2)
Actual Study Start Date :
May 30, 2018
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
May 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Health Living Attention Control

Participants in the attention control condition will receive a healthy aging educational intervention. This group will receive one in-person health coaching sessions and 6 phone counseling sessions.

Behavioral: Health Coaching
Health Coaching sessions will be aimed at goal setting, implementing strategies, overcoming barriers, & relapse prevention.

Experimental: Reduce Sitting

Participants in the Reduce Sitting condition will receive an intervention aimed at reducing daily sitting time. This group will receive five in-person health coaching sessions and two phone counseling sessions.

Behavioral: Health Coaching
Health Coaching sessions will be aimed at goal setting, implementing strategies, overcoming barriers, & relapse prevention.

Device: activPAL inclinometer
Participants in the intervention study arms (B & C) will wear the ActivPAL device for the first 4 weeks of the program and then again in weeks 8 and 9. The device will monitor their sitting and standing time and will allow Health Coaches to provide feedback and will assist the participant in developing an action plan.

Other: Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
Participants in the intervention study arms (B & C) will receive tools to prompt standing or sit-to-stand transitions such as wearable wrist devices, standing desks or tables (Group B only), mechanical and/or electronic timers, or access to mobile apps or computer programs.

Experimental: Sit-to-Stand Transition

Participants in the Sit-to-Stand Transition condition will receive an intervention aimed at increasing the daily number of brief sit-to-stand transitions. This group will receive five in-person health coaching sessions and two phone counseling sessions.

Behavioral: Health Coaching
Health Coaching sessions will be aimed at goal setting, implementing strategies, overcoming barriers, & relapse prevention.

Device: activPAL inclinometer
Participants in the intervention study arms (B & C) will wear the ActivPAL device for the first 4 weeks of the program and then again in weeks 8 and 9. The device will monitor their sitting and standing time and will allow Health Coaches to provide feedback and will assist the participant in developing an action plan.

Other: Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
Participants in the intervention study arms (B & C) will receive tools to prompt standing or sit-to-stand transitions such as wearable wrist devices, standing desks or tables (Group B only), mechanical and/or electronic timers, or access to mobile apps or computer programs.

Outcome Measures

Primary Outcome Measures

  1. Glucose Regulation [3 months]

    Investigate the 12 week effects of increased standing and additional brief sit-to-stand compared to attention controls.

Secondary Outcome Measures

  1. Functional Changes [3 months]

    1. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on physical, emotional & cognitive functioning.

  2. Mitochondrial Function [3 months]

    2. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on in vivo skeletal muscle mitochondrial function.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Female;

  2. 55 years of age and above;

  3. any ethnicity or race;

  4. screened to sit for 7 or more hours per day, perform less than 70 sit-to-stand transitions per day

  5. ambulatory;

  6. medically stable without any health conditions that would inhibit standing or PA;

  7. able to give informed consent & comply with study protocols;

  8. able to read and write fluently in English;

  9. able to travel to study visits; and

  10. no menstruation for at least one year;

  11. BMI 25-45

  12. able to walk, stand and transition without high risk of falling.

Exclusion Criteria:
  1. Male;

  2. younger than 55 years of age;

  3. sit for less than 7 hours per day, perform 71 or more sit-to-stand transitions per day

  4. mental state that would preclude complete understanding of the protocol or compliance;

  5. physical limitations to completing any of the study conditions;

  6. menstruation less than one year prior;

  7. unable to complete the Short Physical Performance Battery,

  8. Active cancer

  9. body Mass Index <25 or >45kg/m2,

  10. use of insulin

Contacts and Locations

Locations

Site City State Country Postal Code
1 UC San Diego La Jolla California United States 92093

Sponsors and Collaborators

  • University of California, San Diego

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheri Hartman, Assistant Professor, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT03473145
Other Study ID Numbers:
  • 1P01AG052352-01A1
First Posted:
Mar 22, 2018
Last Update Posted:
May 24, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 24, 2022